Dennis Kyle
Affiliations: | Public Health | University of South Florida, Tampa, FL, United States |
Area:
Parasitology Biology, Molecular Biology, Public HealthGoogle:
"Dennis Kyle"Cross-listing: PHTree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schafer C, Dambrauskas N, Steel RW, et al. (2018) A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages. Malaria Journal. 17: 370 |
| Pearce C, Darveaux B, Rice C, et al. (2016) The discovery and evaluation of anti-parasitic metabolites from filamentous fungi. Planta Medica. 81: S1-S381 |
| Obaldía Iii N, Dow GS, Gerena L, et al. (2016) Altered drug susceptibility during host adaptation of a Plasmodium falciparum strain in a non-human primate model. Scientific Reports. 6: 21216 |
| Baragaña B, Hallyburton I, Lee MC, et al. (2015) A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 522: 315-20 |
| Jiménez-Díaz MB, Ebert D, Salinas Y, et al. (2014) (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proceedings of the National Academy of Sciences of the United States of America. 111: E5455-62 |
| Henrich PP, O'Brien C, Sáenz FE, et al. (2014) Evidence for pyronaridine as a highly effective partner drug for treatment of artemisinin-resistant malaria in a rodent model. Antimicrobial Agents and Chemotherapy. 58: 183-95 |
| Siegel S, Rivero A, Kyle D. (2014) Molecular basis of extreme resistance in Plasmodium falciparum to atovaquone and other mitochondrial inhibitors Malaria Journal. 13: 81 |
| Hott A, Casandra D, Sparks K, et al. (2014) Novel phenotypic resistance to artemisinin results in reduced exposure to drug at the most sensitive stage of intraerythrocytic development in Plasmodium falciparum Malaria Journal. 13: 43 |
| Knestrick M, Demers D, Fleeman R, et al. (2014) An epigentic-based fungal metabolite screening protocol for discovery of potential lead compounds for drug treatments Planta Medica. 80 |
| Nilsen A, LaCrue AN, White KL, et al. (2013) Quinolone-3-diarylethers: a new class of antimalarial drug. Science Translational Medicine. 5: 177ra37 |